NCT00531284 2017-08-15Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or LymphomaAmgenPhase 1/2 Completed184 enrolled 36 charts
NCT01949532 2017-05-02Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Multiple Myeloma and Renal DiseaseAmgenPhase 1 Completed26 enrolled 41 charts